Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Hospital-Acquired Infection Control market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hospital-Acquired Infection Controlmarket, defines the market attractiveness level of Hospital-Acquired Infection Control market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hospital-Acquired Infection Control industry, describes the types of Hospital-Acquired Infection Control market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hospital-Acquired Infection Control market and the development prospects and opportunities of Hospital-Acquired Infection Control industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hospital-Acquired Infection Control market in Chapter 13.
By Player:
Alere
Merck
Pfizer
Getinge Group
BD
3M
Cepheid
GlaxoSmithKline
By Type:
Catheter-associated urinary tract infections (CAUTIs)
Surgical site infections (SSIs)
Central line-associated bloodstream infections (CLABSIs)
Respiratory infections
By End-User:
Hospitals and ICUs
Outpatient care centers
Long-term care facilities (LTCFs)
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hospital-Acquired Infection Control Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hospital-Acquired Infection Control Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hospital-Acquired Infection Control Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hospital-Acquired Infection Control Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hospital-Acquired Infection Control Market Analysis and Outlook to 2022
-
7.1 Global Hospital-Acquired Infection Control Consumption (2017-2022)
-
7.2 United States Hospital-Acquired Infection Control Consumption (2017-2022)
-
7.3 Europe Hospital-Acquired Infection Control Consumption (2017-2022)
-
7.4 China Hospital-Acquired Infection Control Consumption (2017-2022)
-
7.5 Japan Hospital-Acquired Infection Control Consumption (2017-2022)
-
7.6 India Hospital-Acquired Infection Control Consumption (2017-2022)
-
7.7 South Korea Hospital-Acquired Infection Control Consumption (2017-2022)
8 Region and Country-wise Hospital-Acquired Infection Control Market Analysis and Outlook to 2028
-
8.1 Global Hospital-Acquired Infection Control Consumption Forecast (2022-2028)
-
8.2 United States Hospital-Acquired Infection Control Consumption Forecast (2022-2028)
-
8.3 Europe Hospital-Acquired Infection Control Consumption Forecast (2022-2028)
-
8.4 China Hospital-Acquired Infection Control Consumption Forecast (2022-2028)
-
8.5 Japan Hospital-Acquired Infection Control Consumption Forecast (2022-2028)
-
8.6 India Hospital-Acquired Infection Control Consumption Forecast (2022-2028)
-
8.7 South Korea Hospital-Acquired Infection Control Consumption Forecast (2022-2028)
9 Global Hospital-Acquired Infection Control Market Outlook by Types and Applications to 2022
-
9.1 Global Hospital-Acquired Infection Control Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Catheter-associated urinary tract infections (CAUTIs) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Surgical site infections (SSIs) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Central line-associated bloodstream infections (CLABSIs) Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Respiratory infections Consumption and Growth Rate (2017-2022)
-
9.2 Global Hospital-Acquired Infection Control Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals and ICUs Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Outpatient care centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Long-term care facilities (LTCFs) Consumption and Growth Rate (2017-2022)
10 Global Hospital-Acquired Infection Control Market Outlook by Types and Applications to 2028
-
10.1 Global Hospital-Acquired Infection Control Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Catheter-associated urinary tract infections (CAUTIs) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Surgical site infections (SSIs) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Central line-associated bloodstream infections (CLABSIs) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Respiratory infections Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hospital-Acquired Infection Control Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals and ICUs Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Outpatient care centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Long-term care facilities (LTCFs) Consumption Forecast and Growth Rate (2022-2028)
11 Global Hospital-Acquired Infection Control Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hospital-Acquired Infection Control Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hospital-Acquired Infection Control Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hospital-Acquired Infection Control Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hospital-Acquired Infection Control Market Competitive Analysis
-
14.1 Alere
-
14.1.1 Alere Company Details
-
14.1.2 Alere Hospital-Acquired Infection Control Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Alere Hospital-Acquired Infection Control Product and Service
-
14.2 Merck
-
14.2.1 Merck Company Details
-
14.2.2 Merck Hospital-Acquired Infection Control Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck Hospital-Acquired Infection Control Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Hospital-Acquired Infection Control Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Hospital-Acquired Infection Control Product and Service
-
14.4 Getinge Group
-
14.4.1 Getinge Group Company Details
-
14.4.2 Getinge Group Hospital-Acquired Infection Control Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Getinge Group Hospital-Acquired Infection Control Product and Service
-
14.5 BD
-
14.5.1 BD Company Details
-
14.5.2 BD Hospital-Acquired Infection Control Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 BD Hospital-Acquired Infection Control Product and Service
-
14.6 3M
-
14.6.1 3M Company Details
-
14.6.2 3M Hospital-Acquired Infection Control Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 3M Hospital-Acquired Infection Control Product and Service
-
14.7 Cepheid
-
14.7.1 Cepheid Company Details
-
14.7.2 Cepheid Hospital-Acquired Infection Control Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Cepheid Hospital-Acquired Infection Control Product and Service
-
14.8 GlaxoSmithKline
-
14.8.1 GlaxoSmithKline Company Details
-
14.8.2 GlaxoSmithKline Hospital-Acquired Infection Control Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 GlaxoSmithKline Hospital-Acquired Infection Control Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hospital-Acquired Infection Control
-
Figure Hospital-Acquired Infection Control Picture
-
Table Global Hospital-Acquired Infection Control Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hospital-Acquired Infection Control Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hospital-Acquired Infection Control Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hospital-Acquired Infection Control Consumption by Country (2017-2022)
-
Figure United States Hospital-Acquired Infection Control Consumption and Growth Rate (2017-2022)
-
Table Europe Hospital-Acquired Infection Control Consumption and Growth Rate (2017-2022)
-
Figure China Hospital-Acquired Infection Control Consumption and Growth Rate (2017-2022)
-
Figure Japan Hospital-Acquired Infection Control Consumption and Growth Rate (2017-2022)
-
Figure India Hospital-Acquired Infection Control Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hospital-Acquired Infection Control Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital-Acquired Infection Control Consumption Forecast by Country (2022-2028)
-
Figure United States Hospital-Acquired Infection Control Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hospital-Acquired Infection Control Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hospital-Acquired Infection Control Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hospital-Acquired Infection Control Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hospital-Acquired Infection Control Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hospital-Acquired Infection Control Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Catheter-associated urinary tract infections (CAUTIs) Consumption and Growth Rate (2017-2022)
-
Figure Global Surgical site infections (SSIs) Consumption and Growth Rate (2017-2022)
-
Figure Global Central line-associated bloodstream infections (CLABSIs) Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory infections Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals and ICUs Consumption and Growth Rate (2017-2022)
-
Figure Global Outpatient care centers Consumption and Growth Rate (2017-2022)
-
Figure Global Long-term care facilities (LTCFs) Consumption and Growth Rate (2017-2022)
-
Figure Global Catheter-associated urinary tract infections (CAUTIs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Surgical site infections (SSIs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Central line-associated bloodstream infections (CLABSIs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Respiratory infections Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals and ICUs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Outpatient care centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Long-term care facilities (LTCFs) Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hospital-Acquired Infection Control Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hospital-Acquired Infection Control Export by Region (Top 5 Countries) (2017-2028)
-
Table Alere (Foundation Year, Company Profile and etc.)
-
Table Alere Hospital-Acquired Infection Control Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alere Hospital-Acquired Infection Control Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Hospital-Acquired Infection Control Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Hospital-Acquired Infection Control Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Hospital-Acquired Infection Control Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Hospital-Acquired Infection Control Product and Service
-
Table Getinge Group (Foundation Year, Company Profile and etc.)
-
Table Getinge Group Hospital-Acquired Infection Control Sales, Price, Value and Gross Profit (2017-2022)
-
Table Getinge Group Hospital-Acquired Infection Control Product and Service
-
Table BD (Foundation Year, Company Profile and etc.)
-
Table BD Hospital-Acquired Infection Control Sales, Price, Value and Gross Profit (2017-2022)
-
Table BD Hospital-Acquired Infection Control Product and Service
-
Table 3M (Foundation Year, Company Profile and etc.)
-
Table 3M Hospital-Acquired Infection Control Sales, Price, Value and Gross Profit (2017-2022)
-
Table 3M Hospital-Acquired Infection Control Product and Service
-
Table Cepheid (Foundation Year, Company Profile and etc.)
-
Table Cepheid Hospital-Acquired Infection Control Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cepheid Hospital-Acquired Infection Control Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Hospital-Acquired Infection Control Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Hospital-Acquired Infection Control Product and Service
-
